Canada · Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 445.41 million. The enterprise value is 435.02 million.
| Market Cap | 445.41M |
| Enterprise Value | 435.02M |
Important Dates
The next estimated earnings date is Thursday, November 6, 2025.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 32.14 million shares outstanding. The number of shares has increased by 4.33% in one year.
| Current Share Class | 32.14M |
| Shares Outstanding | 32.14M |
| Shares Change (YoY) | +4.33% |
| Shares Change (QoQ) | -5.42% |
| Owned by Insiders (%) | 22.44% |
| Owned by Institutions (%) | 11.12% |
| Float | 14.43M |
Valuation Ratios
The trailing PE ratio is 126.38 and the forward PE ratio is 58.65.
| PE Ratio | 126.38 |
| Forward PE | 58.65 |
| PS Ratio | 2.44 |
| PB Ratio | 7.53 |
| P/TBV Ratio | 23.46 |
| P/FCF Ratio | 81.20 |
| P/OCF Ratio | 54.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.18, with an EV/FCF ratio of 79.31.
| EV / Earnings | 115.27 |
| EV / Sales | 2.38 |
| EV / EBITDA | 46.18 |
| EV / EBIT | 63.26 |
| EV / FCF | 79.31 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.34 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | 1.41 |
| Interest Coverage | 7.19 |
Financial Efficiency
Return on equity (ROE) is 6.70% and return on invested capital (ROIC) is 6.41%.
| Return on Equity (ROE) | 6.70% |
| Return on Assets (ROA) | 4.53% |
| Return on Invested Capital (ROIC) | 6.41% |
| Return on Capital Employed (ROCE) | 10.85% |
| Revenue Per Employee | 1.13M |
| Profits Per Employee | 23,296 |
| Employee Count | 162 |
| Asset Turnover | 1.93 |
| Inventory Turnover | 6.40 |
Taxes
In the past 12 months, Kits Eyecare has paid 2.02 million in taxes.
| Income Tax | 2.02M |
| Effective Tax Rate | 34.85% |
Stock Price Statistics
The stock price has increased by +37.30% in the last 52 weeks. The beta is 0.27, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +37.30% |
| 50-Day Moving Average | 15.96 |
| 200-Day Moving Average | 13.18 |
| Relative Strength Index (RSI) | 32.13 |
| Average Volume (20 Days) | 65,548 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 182.88 million and earned 3.77 million in profits. Earnings per share was 0.11.
| Revenue | 182.88M |
| Gross Profit | 65.18M |
| Operating Income | 6.88M |
| Pretax Income | 5.79M |
| Net Income | 3.77M |
| EBITDA | 8.45M |
| EBIT | 6.88M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 18.12 million in cash and 7.72 million in debt, giving a net cash position of 10.39 million or 0.32 per share.
| Cash & Cash Equivalents | 18.12M |
| Total Debt | 7.72M |
| Net Cash | 10.39M |
| Net Cash Per Share | 0.32 |
| Equity (Book Value) | 59.17M |
| Book Value Per Share | 1.84 |
| Working Capital | 10.45M |
Cash Flow
In the last 12 months, operating cash flow was 8.10 million and capital expenditures -2.62 million, giving a free cash flow of 5.49 million.
| Operating Cash Flow | 8.10M |
| Capital Expenditures | -2.62M |
| Free Cash Flow | 5.49M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 35.64%, with operating and profit margins of 3.76% and 2.06%.
| Gross Margin | 35.64% |
| Operating Margin | 3.76% |
| Pretax Margin | 3.17% |
| Profit Margin | 2.06% |
| EBITDA Margin | 4.62% |
| EBIT Margin | 3.76% |
| FCF Margin | 3.00% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.33% |
| Shareholder Yield | -4.33% |
| Earnings Yield | 0.85% |
| FCF Yield | 1.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 7.51 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.51 |
| Piotroski F-Score | 7 |